Relaxation induced by cGMP phosphodiesterase inhibitors sildenafil and zaprinast in human vessels
- 31 October 2000
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 70 (4) , 1327-1331
- https://doi.org/10.1016/s0003-4975(00)01914-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Use of Sildenafil (Viagra) in Patients With Cardiovascular DiseaseCirculation, 1999
- SILDENAFIL, A TYPE-5 CGMP PHOSPHODIESTERASE INHIBITOR, SPECIFICALLY AMPLIFIES ENDOGENOUS cGMP-DEPENDENT RELAXATION IN RABBIT CORPUS CAVERNOSUM SMOOTH MUSCLE IN VITROJournal of Urology, 1998
- EFFECTS OF SILDENAFIL ON THE RELAXATION OF HUMAN CORPUS CAVERNOSUM TISSUE IN VITRO AND ON THE ACTIVITIES OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ISOZYMESJournal of Urology, 1998
- Oral Sildenafil in the Treatment of Erectile DysfunctionNew England Journal of Medicine, 1998
- Does severity of ischemic coronary disease correlate with erectile function?International Journal Of Impotence Research, 1997
- Sildenafil, a novel effective oral therapy for male erectile dysfunctionBritish Journal of Urology, 1996
- Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase.Hypertension, 1994
- Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitorsTrends in Pharmacological Sciences, 1990
- Cyclic guanosine monophosphate as a mediator of vasodilation.Journal of Clinical Investigation, 1986
- Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphatidylinositol hydrolysis in rat aorta.Circulation Research, 1986